Two Sigma Advisers’s PDS Biotechnology PDSB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-109,100
| Closed | -$542K | – | 2591 |
|
|
2023
Q4 | $542K | Sell |
109,100
-142,300
| -57% | -$707K | ﹤0.01% | 1892 |
|
|
2023
Q3 | $1.27M | Sell |
251,400
-160,000
| -39% | -$808K | ﹤0.01% | 1424 |
|
|
2023
Q2 | $2.07M | Sell |
411,400
-173,000
| -30% | -$870K | 0.01% | 1182 |
|
|
2023
Q1 | $3.59M | Buy |
584,400
+25,200
| +5% | +$155K | 0.01% | 961 |
|
|
2022
Q4 | $7.38M | Buy |
559,200
+146,669
| +36% | +$1.94M | 0.02% | 611 |
|
|
2022
Q3 | $1.23M | Sell |
412,531
-130,769
| -24% | -$388K | ﹤0.01% | 1423 |
|
|
2022
Q2 | $1.98M | Buy |
543,300
+11,000
| +2% | +$40.1K | 0.01% | 1221 |
|
|
2022
Q1 | $3.3M | Buy |
532,300
+5,400
| +1% | +$33.4K | 0.01% | 1000 |
|
|
2021
Q4 | $4.27M | Buy |
526,900
+48,500
| +10% | +$393K | 0.01% | 837 |
|
|
2021
Q3 | $7.13M | Buy |
+478,400
| New | +$7.13M | 0.02% | 630 |
|
|
2020
Q3 | – | Sell |
-32,800
| Closed | -$66K | – | 2585 |
|
|
2020
Q2 | $66K | Buy |
+32,800
| New | +$66K | ﹤0.01% | 2407 |
|
|
2019
Q1 | – | Sell |
-3,155
| Closed | -$20K | – | 2422 |
|
|
2018
Q4 | $20K | Sell |
3,155
-20
| -0.6% | -$127 | ﹤0.01% | 2310 |
|
|
2018
Q3 | $52K | Buy |
3,175
+1,535
| +94% | +$25.1K | ﹤0.01% | 2173 |
|
|
2018
Q2 | $34K | Buy |
+1,640
| New | +$34K | ﹤0.01% | 2316 |
|